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Abstract
Biliary atresia (BA) is classically described at the neonatal age. However, rare cases of BA in older infants have also been reported. We
report four cases of late-onset BA in infants older than 4 weeks (3 males, 1 female), and describe the diagnostic and management
difficulties. One of the cases had a late-onset (29 weeks) presentation with a successful surgical procedure. We highlight the importance
of this unusual differential diagnosis in infants with cholestatic syndrome, who may benefit from Kasai surgery, regardless of age.
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Introduction
Biliary atresia (BA) is still a challenge for clinicians and
researchers. This disease is classically described in neo-
nates and its early diagnosis is fundamental for a better
prognosis (1). Viral etiological agents, such as cytomega-
lovirus, defects in morphogenesis of the biliary tree, and
genetic, epigenetic, ischemic, inflammatory, immune, and
even toxic factors (2,3), alone or combined, have been
implicated in the etiopathogenesis of BA. However, the
mechanisms of BA are still largely unknown. BA commonly
manifests in the first month of life. Nevertheless, late-onset
forms, as well as successful Kasai portoenterostomy pro-
cedures in older children, have been observed (4), reflecting
the heterogeneous nature of BA. Yang et al. (5) classified
BA according to the time of onset of symptoms as early-
onset and late-onset forms. They defined these early- and
late-onset forms as cholestatic jaundice and fecal hypocho-
lia before and after 2 weeks of life, respectively.
In this report, we describe four cases of late-onset BA
in infants older than 4 weeks and their histopathological
findings. We highlight the importance of this diagnosis in
infants with cholestatic syndrome and the diagnostic and
management difficulties. Our findings reinforce that failure
of early diagnosis may result in delayed indication of
optimal surgical procedures.
Case Reports
All cases of BA originated from patients who were
treated between 2006 and 2012 at the Departamento de
Pediatria, Faculdade de Ciências Médicas, Universidade
Estadual de Campinas (FCM, UNICAMP), Campinas, SP,
Brazil. The present report was approved by the Ethics
Committee of the Departamento de Pediatria, FCM,
UNICAMP, Brazil. After chart analyses and case descrip-
tions, histological slides were reviewed independently by
two pathologists.
Case 1
This patient was a male infant, aged 31 weeks and
1 day, with a history of jaundice, choluria, and fecal hypo-
cholia that had begun 2 weeks prior. The infant was born at
40 weeks of gestational age, weighed 3600 g, and had no
history of neonatal jaundice or other comorbid conditions.
The mother had gestational diabetes and was exclusively
treated with diet. Baseline biochemical tests were consistent
with cholestatic syndrome (baseline biochemical tests of all
four cases are shown in Table 1). Serology for cytomega-
lovirus was negative. Abdominal ultrasound at admission to
the hospital showed an enlarged liver, with slightly hetero-
geneous parenchyma, a distended gallbladder, and dilata-
tion of the intrahepatic and extrahepatic systems. After an
inconclusive clinical investigation, the infant underwent
exploratory laparotomy at 37 weeks and 1 day old. We
observed a gallbladder with a thin and distended wall,
adherence of the intestinal loops to the hilum of the liver,
and an indurated, fibrotic, extrahepatic bile duct system.
Transoperative cholangiography showed that there was
failure to fill at the junction of the hepatic ducts and a lack of
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drainage to the small intestine. Kasai portoenterostomy was
the treatment of choice. The infant showed significant
clinical improvement and normalization of bilirubin levels
1 week after surgery. He is currently asymptomatic after
65 months of follow-up.
Case 2
This patient was a male infant, aged 17 weeks and
4 days, with a history of isolated jaundice since 8 weeks of
life. There were no complications in prenatal care. The infant
was born at 40 weeks and 2 days of gestational age, and
weighed 3150 g. Baseline clinical investigations showed an
isolated increase in direct bilirubin serum levels, a liver with a
heterogeneous parenchyma, and a non-contractile gallblad-
der on abdominal ultrasound. Serology for cytomegalovirus
was negative. Percutaneous liver biopsy was performed,
with histopathological findings consistent with BA, at a stage
of focal nodular transformation. Because of the older age at
onset and the atypical clinical picture for BA, primary scle-
rosing cholangitis was initially considered. Final diagnosis
was dependent on findings at exploratory laparotomy, which
showed a macroscopically normal gallbladder, an extra-
hepatic biliary system, as well as the usual appearance of
the liver. Transoperative cholangiography revealed a minute
streak of contrast material ascending the intrahepatic bile
duct system. We decided to interrupt the Kasai operation
and only perform cholecystectomy and wedge biopsy of the
liver. The child rapidly progressed to liver cirrhosis and the
diagnosis of biliary atresia was considered at this moment.
The child deteriorated before transplantation was attempted.
Case 3
This patient was a male infant, aged 14 weeks, with
clinical presentation of jaundice, choluria, and fecal hypocho-
lia for 2 weeks. The infant was born at 39 weeks gestational
age and weighed 3320 g. He presented with jaundice on the
second day of life, was treated with phototherapy, and dis-
charged from the hospital with improvement of symptoms.
The mother had a history of deep venous thrombosis and
used prophylactic heparin during pregnancy. On initial in-
vestigation, biochemical tests were typical of cholestatic
syndrome. Serology for cytomegalovirus was negative.
Abdominal ultrasound failed to visualize the gallbladder during
fasting. Percutaneous liver biopsy was attempted without suc-
cess. Our treatment of choice was exploratory laparotomy at
15 weeks and 4 days of age. This procedure showed the
gallbladder and extrahepatic bile duct systems with total
atresia. Kasai portoenterostomy was performed. After surgery,
there was partial improvement of clinical and laboratory para-
meters, and the infant received referral for liver transplanta-
tion, which was performed at another hospital. He was lost to
follow-up immediately after the procedure.
Case 4
This patient was a female infant, aged 9 weeks and
4 days, with clinical presentation of jaundice, choluria, and
fecal hypocholia, with an onset of 5 weeks. Prenatal care
showed no complications. She was born at a gestational
age of 39 weeks, weighed 2625 g, and had no comorbid
conditions. Baseline biochemical tests were consistent with
cholestatic syndrome. Serology for cytomegalovirus was
negative. Abdominal ultrasound revealed a hypoplastic
gallbladder and a liver with a normal aspect. Percutaneous
liver biopsy showed histopathological findings typical of BA.
Exploratory laparotomy at 10 weeks and 5 days old showed
atresia of the extrahepatic bile duct system, an intensely
hypoplastic gallbladder, and an enlarged, firm, micronodular
liver. After surgery, the infant progressed with partial
improvement in clinical and laboratory parameters. She
was referred for liver transplantation, which was performed
at another hospital, and was lost to follow-up afterward.
Results
All liver biopsies that were obtained during exploratory
laparotomy exhibited a morphological pattern typical of
large bile duct obstruction, with severe portal biliary
reaction, ductal, intracanalicular, and hepatocytic choles-
tasis, and cholatestasis. We also observed focal nodular
regeneration and giant cell transformation of some sparse
hepatocytes (Figure 1). Thickening of the portal branches
of the hepatic artery was also observed (Figure 2). Case 1
exhibited type 2 porta hepatis (6), a common bile duct with
ductal lumens in the midst of loose fibrous tissue, and a
gallbladder with considerable luminal dilatation. Case 3
also demonstrated type 2 porta hepatis, associated with
chronic inflammation, with an extrahepatic biliary system
and a gallbladder with complete atresia. In case 4, biliary
remnants were not visualized, raising the question as to
whether it was type 1 porta hepatis or an artifact. The
gallbladder showed the usual histological aspect as in
cases 2 and 4.
Discussion
Since 1959, Kasai portoenterostomy has been the
only treatment, with the exception of liver transplantation,
Table 1. Baseline biochemical tests.
Case BT (mg/dL) BD (mg/dL) AP (U/L) GGT (U/L)
1 12.6 9.0 3.1 1.3
2 27.3 20.4 334.0 108.0
3 9.0 7.3 774.0 1.1
4 14.0 9.2 603.0 957.0
BT: total bilirubin; BD: direct bilirubin; AP: alkaline phosphatase;
GGT: gamma-glutamyl transpeptidase. Reference values: BT,
o1 mg/dL; BD, o0.3 mg/dL; AP, o449 U/L (6 days to 6 months)
and o462 U/L (7 months to 1 year old); GGT, o204 U/L (6 days
to 6 months) and o34 U/L (7 months to 1 year).
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that effectively changes the prognosis of patients with BA.
Several studies have sought objective clinical, histopatho-
logical, laboratory, or imaging criteria that could help in
treatment decision-making and have prognostic value in
children with BA. In this context, whether there is an age
limit for the Kasai procedure is unknown. Large series have
associated the success of this surgery to the age of the
patients; the younger the patient, the better the prognosis.
However, because BA has a higher incidence in neonates,
these results might have been biased against analysis of
age alone. This is probably because in several cases
undergoing late surgery, diagnosis had been made at an
advanced stage of disease. BA is currently accepted as a
heterogeneous disease, with various forms of clinical
presentation. Therefore, the distinction between ‘‘late diag-
nosis’’ and ‘‘late onset’’ of BA may be important. Late-onset
forms with a shorter duration of disease are likely to have a
favorable outcome after the Kasai procedure, even when
the patient is older. Nevertheless, there are also case
reports with a late diagnosis where the patient benefitted
from the Kasai operation (7).
Our four cases did not have the same outcome. The first
case was unusual because the child was 31 weeks old and
ultrasound at admission showed intra- and extrahepatic bile
duct dilatation. This finding is only observed in approximately
5% of biliary atresia patients with obstruction at the common
bile duct (8). The initial differential diagnosis did not include
BA. To the best of our knowledge, there are no similar reports
of onset of BA later than 29 weeks of life. Diagnosis was
made by transoperative cholangiography and supported by
histopathological findings. Even at an older age, the Kasai
procedure was the treatment of choice. The child had a
favorable clinical course and continues to be asymptomatic
until the present date. Clinical features of case 1 suggest an
acquired form of BA, which can be associated with perfo-
ration of biliary tracts, as described by Davenport et al. (9).
However, there were no signs of bile duct perforation or a
history of surgical manipulation. The morphological findings
were characteristic of isolated biliary atresia.
In contrast, in case 2, the infant did not undergo Kasai
surgery, even with previous histopathological findings sug-
gestive of BA. The clinical diagnosis was primary sclerosing
cholangitis because of the atypical clinical picture of jaundice
at 8 weeks of life, low serum gamma-glutamyl transpepti-
dase levels, and the absence of fecal hypocholia. The final
diagnosis depended exclusively on surgical findings and
cholangiography that was performed during exploratory
laparotomy. In this case, transoperative cholangiography
showed a minute streak of contrast medium ascending the
intrahepatic bile duct system. This finding was interpreted
by the surgeon as information that ruled out the diagnosis
of BA. This infant progressed with liver cirrhosis and its
complications, and missed the opportunity for an effective
Kasai procedure. The image shown by cholangiography
most probably represented the evolutionary stage of the
disease, with partial obstruction of the bile duct system. This
case highlights the difficulties in diagnosing BA, also de-
monstrating variability in transoperative cholangiography
findings, which are considered the gold standard for diag-
nosis. The third and fourth cases, even at older ages and
with approximately 4 and 6 weeks of symptoms, respec-
tively, underwent Kasai portoenterostomy. However, the
outcome was unfavorable and the infants were referred to
the surgical service for liver transplantation.
Common morphological alterations of BA in liver biopsy
specimens include a periportal ductular reaction, cholestasis,
and portal expansion with edematous fibroplasia, in addition
to fibrous septa and nodules in advanced stages. Findings
such as ductal plate malformation have also been observed
in some cases, suggesting an intrauterine insult in the phy-
siopathogenesis of BA, but with no prognostic significance.
Some researchers have described thickening of the median
layer of the portal branches of the hepatic artery as part of the
histopathological criteria of BA (10,11). A morphometric and
immunohistochemical study on angiogenic factors (vascular
endothelial growth factor A) also supported this observation,
suggesting that ischemia/hypoxia phenomena participate in
the etiopathogenesis of BA (12). An angiographic study
in patients with BA showed alterations in branches of the
Figure 1. Photomicrograph showing the main histological findings
of biliary atresia A portal space with ductular proliferation and
biliary plugs (arrows) can be seen. Masson trichrome stain, 100.
Figure 2. Photomicrograph showing thickening of the arterial
medial layer (arrow). Hematoxylin and eosin stain,  200.
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hepatic artery, such as tortuosities, formation of vascular
arterial tuft-like lesions, and occlusion of peripheral arterial
branches, suggesting that these findings may be char-
acteristic of BA (13). Furthermore, an increase in the re-
sistance index of the hepatic artery, measured by Doppler
ultrasound, has been associated with a worse prognosis
in patients with BA (14).
Classification of BA has experienced several modifi-
cations throughout the years and is inconsistent among
researchers. Two clinical presentations of BA have been
classically described (2). One presentation is embryonic BA,
characterized by persistent jaundice at birth, associated with
non-hepatic congenital structural alterations, also called the
early, fetal, or syndromic form. The other presentation is
perinatal BA, with a jaundice-free interval at birth, is present
alone, and is also called the late or non-syndromic form.
Davenport et al. proposed a new term of ‘‘biliary atresia
splenic malformation syndrome’’ and defined clinical criteria
for the forms of embryonic BA (15). New clinical forms,
supported by imaging and laboratory tests, and prognostic
characteristics have emerged, such as a cystic BA and
a form associated with cytomegalovirus infection (2). An
acquired form of BA, secondary to perforation of the extra-
hepatic biliary system or previous surgical manipulation, has
been described with the same morphological findings (9).
The question of why the acquired form of BA does not
develop in older children, or in adults, remains unanswered.
Variability of frequently superimposed clinical presentations
that are difficult to classify reinforces the hypothesis that BA
represents a group of disorders with distinct etiopathogenic
mechanisms. All of these disorders have the final pathway of
progressive destructive inflammatory obliterative cholangio-
pathy in common.
In summary, we describe four late-onset cases of BA,
highlighting the importance of this differential diagnosis
not only in neonates, but also in infants with cholestatic
syndrome. Every case should be evaluated, based on
clinical, laboratory, histopathological, surgical, and ima-
ging criteria, which are highly variable. BA is still a disease
with many unanswered questions, and its diagnosis can
be a challenge. Therefore, the experience of the reference
center is extremely important. Management should be
individualized, regardless of the age of the patient. We are
currently performing a morphometric study of the portal
branches of the hepatic artery in all cases with wedged
liver biopsy in our service. We hope to understand the
actual associations between these morphologic data and
BA, its clinical forms, and the time of disease.
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